Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

NCT04428814 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

BIOLOGICAL: CT-P43
BIOLOGICAL: EU-approved Stelara
BIOLOGICAL: US-licensed Stelara

Sponsor

Celltrion